Pharma Journalist -

Biogen Inc. and Samsung Bioepis announced that they will present new real-world data from the companies’ anti-TNF biosimilar portfolio, which includes FLIXABI (infliximab) and IMRALDI…
Read More...

SMi Reports: Overview of the workshops for Europe’s only Parallel Trade conference and exhibition taking place in February 2020 in London. SMi’s highly anticipated Parallel Trade…
Read More...

Alexion Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) approved ULTOMIRIS (ravulizumab-cwvz) for the treatment of atypical hemolytic uremic syndrome (aHUS)…
Read More...

Boston – October 18, 2020 Continuous process first gained pharma and biotech’s attention in early 2010. It has taken Vertex and Janssen years before Symdeko and PREZISTA approved by…
Read More...

SMi Reports: James Drinkwater and Olivier Chancel release an invitation chair letter for the Pharmaceutical Microbiology Conference, in London. SMi Group is delighted to present the…
Read More...

Merck, known as MSD outside the United States and Canada, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a…
Read More...

Thermo Fisher Scientific, the world leader in serving science, announced the availability of the Thermo Scientific Acrometrix BCR-ABL Panel, its latest molecular quality control panel.…
Read More...

Horizon Therapeutics plc announced it has initiated an open-label clinical trial evaluating the use of KRYSTEXXA (pegloticase injection) in adults with chronic gout refractory to…
Read More...

AstraZeneca and Daiichi Sankyo Company, Limited (Daiichi Sankyo) announced that the US Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA)…
Read More...

ArsenalBio makes its debut today backed by $85 million Series A financing to build a programmable cell therapy company to create highly effective and accessible immune cell therapies.…
Read More...